Association of Cytidine Deaminase Polymorphism with Capecitabine Effectiveness in Breast Cancer Patients

Volume 24, Issue 12, December 2023, Pages 4219-4225

Ali Amal Aldeen Majeed; Ahmed Salih Sahib; Hasanian Shakir Mahmood; Karar Kadhim Mohsin; Raaid Fadhl Abbas

• View Article
• PDF 436.78 K

Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?

Volume 23, Issue 5, May 2022, Pages 1733-1740

Ayatallah A Youssief; Doaa A Gamal; M S El-Naggar; Mohamed A Zarzor; Refaat A; Shimaa Ahmed

• View Article
• PDF 545.08 K

The Effects of Phyllanthus niruri Linn on Infiltrating Dendritic Cell and Ratio of Neutrophile/Lymphocytes in Chemotherapy of Sprague-Dawley Rats with Colorectal Cancer

Volume 22, Issue 11, November 2021, Pages 3561-3568

Michael Tendean; Ignatius Riwanto

• View Article
• PDF 671.72 K

Low Incidence of the DPD IVS14+1G>A Polymorphism in Jordanian Breast and Colorectal Cancer patients

Volume 18, Issue 6, June 2017, Pages 1651-1654

Mohammad Al-khateeb; Abdalla Awidi; Kamal Al-Hadidi; Abdelkader Battah

• View Article
• PDF 323.98 K

An Updated Meta-analysis and System Review:is emcitabine+Fluoropyrimidine in Combination a Better herapy Versus Gemcitabine Alone for Advanced and Unresectable Pancreatic Cancer?

Volume 16, Issue 14, December 2015, Pages 5681-5686

• View Article
• PDF 979.15 K

Aromatase Inhibition and Capecitabine Combination as 1st or 2nd Line Treatment for Metastatic Breast Cancer - a Retrospective Analysis

Volume 16, Issue 15, December 2015, Pages 6359-6364

• View Article
• PDF 459.1 K

Capecitabine Pattern of Usage, Rate of Febrile Neutropaenia and Treatment Related Death in Asian Cancer Patients in Clinical Practice

Volume 16, Issue 4, April 2015, Pages 1449-1453

• View Article
• PDF 352.45 K

Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer

Volume 15, Issue 17, December 2014, Pages 7119-7123

• View Article
• PDF 586.62 K

Modified Docetaxel and Cisplatin in Combination with Capecitabine (DCX) as a First-Line Treatment in HER2-Negative Advanced Gastric Cancer

Volume 15, Issue 20, December 2014, Pages 8661-8666

• View Article
• PDF 431.84 K

Adherence to Capecitabine Treatment and Contributing Factors among Cancer Patients in Malaysia

Volume 15, Issue 21, December 2014, Pages 9225-9232

• View Article
• PDF 451.1 K

First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer

Volume 15, Issue 7, July 2014, Pages 3157-3161

• View Article
• PDF 547 K

Lack of Prognostic Value of Mean Corpuscular Volume with Capecitabine Therapy in Metastatic Breast Cancer

Volume 15, Issue 6, June 2014, Pages 2501-2504

• View Article
• PDF 349.95 K

Efficacy and Tolerability of Adjuvant Oral Capecitabine plus Intravenous Oxaliplatin (XELOX) in Asian Patients with Colorectal Cancer: 4-Year Analysis

Volume 14, Issue 11, November 2013, Pages 6585-6590

• View Article
• PDF 568.69 K

Can Capecitabine be used Instead of Concurrent Bolus 5-FU in Postoperative Chemoradiotherapy for Gastric Adenocarcinoma?

Volume 14, Issue 9, September 2013, Pages 5127-5131

• View Article
• PDF 405.41 K

Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions

Volume 14, Issue 4, April 2013, Pages 2283-2288

• View Article
• PDF 416.09 K